Home › ETF database › XLV
XLV Health Care Select Sector SPDR Fund
XLV is a Healthcare ETF issued by State Street. It tracks the S&P 500 Health Care index, costs 0.12% a year, and launched in December 1998.
Composition and assets as of 2026-10-27.
Key facts
| Ticker | XLV |
|---|---|
| Full name | Health Care Select Sector SPDR Fund |
| Issuer | State Street |
| Category | Healthcare |
| Sub-category | S&P Sector |
| Index tracked | S&P 500 Health Care |
| Expense ratio | 0.12% |
| Assets under management | $47.51bn |
| Inception | 22 December 1998 |
| Asset class | Equity |
| Geographic mandate | United States (single country) |
Sector allocation
- Healthcare100%
Geographic mandate
This fund is chartered to hold companies domiciled in the United States. That is one country, so there is nothing to split: the mandate answers the question a percentage would have answered.
Top 10 holdings
- 1Eli Lilly and Co
- 2Johnson & Johnson
- 3AbbVie Inc
- 4Merck & Co Inc
- 5UnitedHealth Group Inc
- 6Thermo Fisher Scientific Inc
- 7Amgen Inc
- 8Gilead Sciences Inc
- 9Abbott Laboratories
- 10Pfizer Inc
Frequently asked
What is XLV's expense ratio?
Health Care Select Sector SPDR Fund charges 0.12% a year — $12 on a $10,000 holding.
What index does XLV track?
Health Care Select Sector SPDR Fund tracks the S&P 500 Health Care index.
How large is XLV?
Our dataset puts XLV at about $47.51bn in assets under management (as of 2026-10-27). Assets move with markets and flows, so treat this as a snapshot rather than a current figure.
What are XLV's largest holdings?
The 10 largest holdings in our dataset are Eli Lilly and Co, Johnson & Johnson, AbbVie Inc, Merck & Co Inc, UnitedHealth Group Inc, Thermo Fisher Scientific Inc, Amgen Inc, Gilead Sciences Inc, Abbott Laboratories and Pfizer Inc.
Where is XLV invested?
It is a single-country fund: the mandate is the United States, and the fund holds companies domiciled there.
Related ETFs
Chosen from the same category where one exists, then from other equity funds in this database.